Payment overview · 2025
General Payments
$138.66
7 reported records · 4 companies
Healthcare provider profile · identity verified
John G Preddy, DO
Allopathic & Osteopathic Physicians|Family Medicine · UVALDE, TX · NPI 1922064955
Verified facts
What the public records show
CMS Open Payments records show John G Preddy, DO received $138.66 in general payments during 2025 across 7 reported records.
Neurocrine BioSciences, Inc. accounted for 49.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ingrezza.
Neurocrine BioSciences, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported INGREZZA as an associated drug or biological on 126456 records involving 27390 distinct recipient NPIs. Public Medicare Part D data also shows 157 claims for Ingrezza by this doctor in 2024.
Novartis Pharmaceuticals Corporation reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ENTRESTO as an associated drug or biological on 9346 records involving 6254 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Entresto by this doctor in 2024.
Teva Pharmaceuticals USA, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AUSTEDO as an associated drug or biological on 28 records involving 15 distinct recipient NPIs. Public Medicare Part D data also shows 29 claims for Austedo by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $68.98 | 49.8% | 4 | 2025 |
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $28.64 | 20.6% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $21.31 | 15.4% | 1 | 2025 |
| Novartis Pharmaceuticals Corporation | Unresolved — no canonical attribution shown | $19.73 | 14.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $138.66 | 7 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $68.98 | 4 | 2025 |
Source payment records
|
|||||
| UZEDY Normalized: uzedy |
Drug | Teva Pharmaceuticals USA, Inc. | $28.64 | 1 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $21.31 | 1 | 2025 |
Source payment records
|
|||||
| PROLIA Normalized: prolia |
Biological | Amgen Inc. | $21.31 | 1 | 2025 |
Source payment records
|
|||||
| LEQVIO Normalized: leqvio |
Drug | Novartis Pharmaceuticals Corporation | $19.73 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| INGREZZA ingrezza |
2025 | Ingrezza | 2024 | 157 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. Exact reporting entity; no affiliate inference |
2025 | INGREZZA open payments reported associated product |
CMS Open Payments — General Payments 126456 supporting records · 27390 recipient NPIs · example record 1242766729 |
Ingrezza · 2024 Exact normalized brand match · 1 Part D row |
157 | 16 |
| Novartis Pharmaceuticals Corporation Exact reporting entity; no affiliate inference |
2025 | ENTRESTO open payments reported associated product |
CMS Open Payments — General Payments 9346 supporting records · 6254 recipient NPIs · example record 1200004797 |
Entresto · 2024 Exact normalized brand match · 1 Part D row |
26 | suppressed by CMS |
| Teva Pharmaceuticals USA, Inc. Exact reporting entity; no affiliate inference |
2025 | AUSTEDO open payments reported associated product |
CMS Open Payments — General Payments 28 supporting records · 15 recipient NPIs · example record 1247249192 |
Austedo · 2024 Exact normalized brand match · 1 Part D row |
29 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1675 | 162 |
| Amlodipine Besylate | Amlodipine Besylate | 1325 | 136 |
| Divalproex Sodium | Divalproex Sodium | 1055 | 55 |
| Metformin Hcl | Metformin Hcl | 1051 | 98 |
| Sertraline Hcl | Sertraline Hcl | 1028 | 61 |
| Donepezil Hcl | Donepezil Hcl | 1000 | 69 |
| Lisinopril | Lisinopril | 941 | 69 |
| Trazodone Hcl | Trazodone Hcl | 930 | 77 |
| Losartan Potassium | Losartan Potassium | 872 | 97 |
| Tamsulosin Hcl | Tamsulosin Hcl | 780 | 63 |
| Gabapentin | Gabapentin | 759 | 86 |
| Levetiracetam | Levetiracetam | 755 | 33 |
| Memantine Hcl | Memantine Hcl | 743 | 45 |
| Pantoprazole Sodium | Pantoprazole Sodium | 725 | 87 |
| Levothyroxine Sodium | Levothyroxine Sodium | 690 | 88 |
| Metoprolol Tartrate | Metoprolol Tartrate | 670 | 57 |
| Furosemide | Furosemide | 661 | 92 |
| Quetiapine Fumarate | Quetiapine Fumarate | 561 | 27 |
| Metoprolol Succinate | Metoprolol Succinate | 541 | 69 |
| Potassium Chloride | Potassium Chloride | 538 | 73 |
| Eliquis | Apixaban | 488 | 55 |
| Simvastatin | Simvastatin | 371 | 28 |
| Januvia | Sitagliptin Phosphate | 338 | 30 |
| Oxcarbazepine | Oxcarbazepine | 327 | 17 |
| Hydrochlorothiazide | Hydrochlorothiazide | 313 | 37 |
| Pravastatin Sodium | Pravastatin Sodium | 310 | 33 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 302 | 14 |
| Omeprazole | Omeprazole | 295 | 37 |
| Fluoxetine Hcl | Fluoxetine Hcl | 288 | 20 |
| Divalproex Sodium Er | Divalproex Sodium | 270 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 266 | 26 |
| Risperidone | Risperidone | 261 | 18 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 254 | 15 |
| Benztropine Mesylate | Benztropine Mesylate | 251 | 11 |
| Mirtazapine | Mirtazapine | 250 | 24 |
| Glipizide | Glipizide | 240 | 18 |
| Carvedilol | Carvedilol | 225 | 38 |
| Hydralazine Hcl | Hydralazine Hcl | 214 | 24 |
| Amiodarone Hcl | Amiodarone Hcl | 212 | 21 |
| Meloxicam | Meloxicam | 211 | 24 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 197 | 25 |
| Olanzapine | Olanzapine | 196 | 12 |
| Clopidogrel | Clopidogrel Bisulfate | 194 | 41 |
| Klor-Con M20 | Potassium Chloride | 186 | suppressed |
| Finasteride | Finasteride | 183 | 14 |
| Spironolactone | Spironolactone | 181 | 24 |
| Naproxen | Naproxen | 165 | 30 |
| Lamotrigine | Lamotrigine | 164 | 12 |
| Duloxetine Hcl | Duloxetine Hcl | 162 | 24 |
| Prednisone | Prednisone | 162 | 32 |
| Citalopram Hbr | Citalopram Hydrobromide | 161 | 19 |
| Famotidine | Famotidine | 161 | 30 |
| Ingrezza | Valbenazine Tosylate | 157 | 16 |
| Topiramate | Topiramate | 156 | 13 |
| Alprazolam | Alprazolam | 154 | 24 |
| Clonazepam | Clonazepam | 152 | 26 |
| Buspirone Hcl | Buspirone Hcl | 148 | 16 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 147 | 14 |
| Jardiance | Empagliflozin | 145 | 18 |
| Montelukast Sodium | Montelukast Sodium | 145 | 24 |
| Farxiga | Dapagliflozin Propanediol | 144 | 13 |
| Invega Sustenna | Paliperidone Palmitate | 141 | 16 |
| Glimepiride | Glimepiride | 137 | 18 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 129 | 20 |
| Sucralfate | Sucralfate | 127 | 12 |
| Lorazepam | Lorazepam | 125 | 28 |
| Paroxetine Hcl | Paroxetine Hcl | 124 | suppressed |
| Haloperidol | Haloperidol | 123 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 121 | 45 |
| Primidone | Primidone | 120 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 119 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 117 | 18 |
| Methylprednisolone | Methylprednisolone | 117 | 86 |
| Acetic Acid | Acetic Acid | 115 | suppressed |
| Allopurinol | Allopurinol | 113 | 13 |
| Nifedipine Er | Nifedipine | 112 | 20 |
| Torsemide | Torsemide | 111 | 16 |
| Pentoxifylline | Pentoxifylline | 109 | suppressed |
| Bumetanide | Bumetanide | 107 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 105 | suppressed |
| Lactulose | Lactulose | 104 | 25 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 100 | 23 |
| Myrbetriq | Mirabegron | 100 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 98 | 25 |
| Bupropion Xl | Bupropion Hcl | 97 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 96 | 60 |
| Azithromycin | Azithromycin | 95 | 78 |
| Methotrexate | Methotrexate Sodium | 95 | suppressed |
| Tradjenta | Linagliptin | 95 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 94 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 93 | 34 |
| Gemfibrozil | Gemfibrozil | 93 | suppressed |
| Xarelto | Rivaroxaban | 93 | 13 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 92 | 19 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 92 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 91 | 21 |
| Ropinirole Hcl | Ropinirole Hcl | 87 | suppressed |
| Latanoprost | Latanoprost | 85 | 18 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 84 | 17 |
| Albuterol Sulfate | Albuterol Sulfate | 82 | 45 |
| Ozempic | Semaglutide | 81 | 21 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 78 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 76 | 47 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 75 | 47 |
| Propranolol Hcl | Propranolol Hcl | 74 | suppressed |
| Ibuprofen | Ibuprofen | 73 | 16 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 73 | 44 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 71 | 20 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 69 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 69 | 30 |
| Digoxin | Digoxin | 68 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 66 | 21 |
| Levofloxacin | Levofloxacin | 65 | 48 |
| Methocarbamol | Methocarbamol | 65 | 17 |
| Cephalexin | Cephalexin | 64 | 41 |
| Phenytoin | Phenytoin | 64 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 64 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 63 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 63 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 62 | 17 |
| Doxepin Hcl | Doxepin Hcl | 62 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 59 | suppressed |
| Carbamazepine | Carbamazepine | 58 | suppressed |
| Chlorthalidone | Chlorthalidone | 57 | suppressed |
| Pregabalin | Pregabalin | 57 | suppressed |
| Aripiprazole | Aripiprazole | 56 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 55 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 54 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 52 | suppressed |
| Amoxicillin | Amoxicillin | 50 | 35 |
| Atenolol | Atenolol | 50 | suppressed |
| Ursodiol | Ursodiol | 50 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 49 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 49 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 49 | suppressed |
| Novolin R | Insulin Regular, Human | 49 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 48 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 48 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 47 | 21 |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 47 | suppressed |
| Sulfasalazine Dr | Sulfasalazine | 46 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 42 | suppressed |
| Rivastigmine | Rivastigmine | 42 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 42 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 41 | 14 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 41 | 18 |
| Enalapril Maleate | Enalapril Maleate | 41 | 12 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 39 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 39 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 37 | suppressed |
| Ofloxacin | Ofloxacin | 37 | 29 |
| Mupirocin | Mupirocin | 36 | 26 |
| Oxycodone Hcl | Oxycodone Hcl | 36 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 36 | suppressed |
| Carbamazepine Er | Carbamazepine | 35 | suppressed |
| Fluconazole | Fluconazole | 35 | 26 |
| Metformin Hcl Er | Metformin Hcl | 35 | suppressed |
| Celecoxib | Celecoxib | 31 | suppressed |
| Fenofibrate | Fenofibrate | 31 | suppressed |
| Rexulti | Brexpiprazole | 31 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 31 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 31 | suppressed |
| Lacosamide | Lacosamide | 30 | suppressed |
| Mounjaro | Tirzepatide | 30 | suppressed |
| Austedo | Deutetrabenazine | 29 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 29 | 14 |
| Megestrol Acetate | Megestrol Acetate | 29 | 11 |
| Oxybutynin Chloride | Oxybutynin Chloride | 29 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 28 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 28 | 17 |
| Constulose | Lactulose | 28 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 28 | suppressed |
| Ezetimibe | Ezetimibe | 28 | suppressed |
| Insulin Lispro | Insulin Lispro | 28 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 28 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 27 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 27 | suppressed |
| Belsomra | Suvorexant | 26 | suppressed |
| Entresto | Sacubitril/Valsartan | 26 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 26 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 26 | suppressed |
| Cefdinir | Cefdinir | 25 | 22 |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 25 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 25 | suppressed |
| Novolog | Insulin Aspart | 25 | suppressed |
| Phenobarbital | Phenobarbital | 25 | suppressed |
| Trulicity | Dulaglutide | 25 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 24 | 18 |
| Clobetasol Propionate | Clobetasol Propionate | 24 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 24 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 24 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 23 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 23 | suppressed |
| Olanzapine Odt | Olanzapine | 23 | suppressed |
| Ondansetron Odt | Ondansetron | 23 | 18 |
| Risperdal Consta | Risperidone Microspheres | 23 | suppressed |
| Humalog | Insulin Lispro | 22 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 22 | suppressed |
| Permethrin | Permethrin | 22 | 13 |
| Raloxifene Hcl | Raloxifene Hcl | 22 | suppressed |
| Cholestyramine Light | Cholestyramine | 21 | suppressed |
| Clonidine | Clonidine | 21 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 21 | suppressed |
| Colchicine | Colchicine | 20 | suppressed |
| Dutasteride | Dutasteride | 20 | suppressed |
| Ertapenem | Ertapenem Sodium | 20 | suppressed |
| Humulin R | Insulin Regular, Human | 20 | suppressed |
| Levemir Flexpen | Insulin Detemir | 20 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 20 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 20 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 20 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 19 | suppressed |
| Trospium Chloride | Trospium Chloride | 19 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 18 | 11 |
| Hydrocortisone | Hydrocortisone | 18 | suppressed |
| Levemir | Insulin Detemir | 18 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 18 | suppressed |
| Felodipine Er | Felodipine | 17 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 17 | suppressed |
| Novolog Flexpen | Insulin Aspart | 17 | suppressed |
| Nystatin | Nystatin | 17 | suppressed |
| Olmesartan-Amlodipine-Hctz | Olmesartan/Amlodipin/Hcthiazid | 17 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 17 | 16 |
| Azelastine Hcl | Azelastine Hcl | 16 | suppressed |
| Budesonide | Budesonide | 16 | suppressed |
| Timolol Maleate | Timolol Maleate | 16 | suppressed |
| Vascepa | Icosapent Ethyl | 16 | suppressed |
| Ampicillin Trihydrate | Ampicillin Trihydrate | 15 | 12 |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 15 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 15 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 15 | suppressed |
| Brilinta | Ticagrelor | 14 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 14 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 14 | 12 |
| Clindamycin Hcl | Clindamycin Hcl | 14 | 11 |
| Enulose | Lactulose | 14 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 14 | suppressed |
| Glipizide Er | Glipizide | 14 | suppressed |
| Ketoconazole | Ketoconazole | 14 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 14 | suppressed |
| Ssd | Silver Sulfadiazine | 14 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 14 | suppressed |
| Clotrimazole | Clotrimazole | 13 | suppressed |
| Dulera | Mometasone/Formoterol | 13 | suppressed |
| Erythromycin | Erythromycin Base | 13 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 13 | suppressed |
| Metronidazole | Metronidazole | 13 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 13 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 13 | 12 |
| Valsartan | Valsartan | 13 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 12 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 12 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 12 | suppressed |
| Estradiol | Estradiol | 12 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 12 | 11 |
| Prednisolone Acetate | Prednisolone Acetate | 12 | suppressed |
| Ranolazine Er | Ranolazine | 12 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 12 | suppressed |
| Baclofen | Baclofen | 11 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 11 | suppressed |
| Indapamide | Indapamide | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Lovastatin | Lovastatin | 11 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $138.66 · 7 records | Neurocrine BioSciences, Inc. | EVENITY, INGREZZA, LEQVIO, PROLIA, UZEDY | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ingrezza play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Neurocrine BioSciences, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error